• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Polyphor - Articles and news items

Polyphor successfully completes Phase I study with POL6014

Industry news / 6 June 2016 / Victoria White, Digital Content Producer

POL6014 is a highly selective, potent and reversible inhibitor of hNE. Increased levels of hNE is associated with cystic fibrosis…

Polyphor awarded $3 million to advance POL6014 in CF

Industry news / 23 March 2016 / Victoria White

Polyphor’s POL6014 reduces the activity of elastase, an enzyme that destroys lung tissue when it is produced in excess…


Webinar: Understanding ISO Standards: ISO 14644-2:2015 Cleanroom MonitoringWATCH NOW
+ +